BANK OF MONTREAL /CAN/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$204,676
-95.6%
12,054
-93.8%
0.00%
-100.0%
Q2 2023$4,628,421
+2213.6%
195,292
+1541.9%
0.00%
Q4 2022$200,057
-28.8%
11,894
-5.2%
0.00%
Q3 2022$281,000
-73.8%
12,543
-74.9%
0.00%
Q2 2022$1,073,000
-36.4%
49,974
-23.7%
0.00%
-100.0%
Q1 2022$1,687,000
+128.9%
65,458
+147.9%
0.00%
Q4 2021$737,000
-22.2%
26,406
-10.0%
0.00%
Q3 2021$947,000
-3.4%
29,351
-8.2%
0.00%
Q2 2021$980,000
+28.9%
31,964
+19.7%
0.00%
Q1 2021$760,000
+22.2%
26,713
+9.4%
0.00%
Q4 2020$622,000
+331.9%
24,419
+125.3%
0.00%
Q3 2020$144,000
+19.0%
10,837
+2.4%
0.00%
Q2 2020$121,000
+290.3%
10,578
+367.0%
0.00%
Q1 2020$31,000
-99.0%
2,265
-98.0%
0.00%
-100.0%
Q4 2019$3,151,000
+37.6%
115,705
+44.6%
0.00%0.0%
Q3 2019$2,290,000
+28.9%
80,017
+25.1%
0.00%
+100.0%
Q2 2019$1,777,000
-41.3%
63,956
-29.9%
0.00%
-66.7%
Q1 2019$3,028,000
+9.0%
91,230
-4.5%
0.00%0.0%
Q4 2018$2,778,000
-35.6%
95,569
+2.0%
0.00%0.0%
Q3 2018$4,311,000
+59.0%
93,722
+29.2%
0.00%
+50.0%
Q2 2018$2,711,000
-1.8%
72,546
-22.3%
0.00%0.0%
Q1 2018$2,760,000
-11.0%
93,420
+3.5%
0.00%
-33.3%
Q4 2017$3,100,000
-61.9%
90,263
-59.9%
0.00%
-57.1%
Q3 2017$8,136,000
+26.9%
224,846
-9.4%
0.01%
+16.7%
Q2 2017$6,410,000
+197.6%
248,085
+121.2%
0.01%
+200.0%
Q1 2017$2,154,000
+21.1%
112,150
+5.2%
0.00%0.0%
Q4 2016$1,779,000
-18.8%
106,621
+0.2%
0.00%0.0%
Q3 2016$2,192,000
-37.1%
106,458
-6.5%
0.00%
-50.0%
Q2 2016$3,484,000
-14.2%
113,852
+5.0%
0.00%0.0%
Q1 2016$4,060,000
+24.2%
108,470
+43.2%
0.00%0.0%
Q4 2015$3,270,000
+50.7%
75,758
+30.8%
0.00%
+33.3%
Q3 2015$2,170,000
+13.4%
57,917
+2.9%
0.00%
+50.0%
Q2 2015$1,913,000
-85.3%
56,292
-84.6%
0.00%
-86.7%
Q1 2015$12,978,000
-11.3%
366,598
-14.7%
0.02%
-11.8%
Q4 2014$14,636,000
-52.7%
429,709
-46.5%
0.02%
-51.4%
Q3 2014$30,954,000
-11.3%
802,536
-10.5%
0.04%
-10.3%
Q2 2014$34,885,000
+22.4%
896,320
+7.5%
0.04%
+5.4%
Q1 2014$28,504,000
+157.7%
833,670
+58.1%
0.04%
+146.7%
Q4 2013$11,063,000
+418.2%
527,243
+480.2%
0.02%
+400.0%
Q3 2013$2,135,000
+10.2%
90,878
+26.0%
0.00%0.0%
Q2 2013$1,938,00072,1070.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders